BAUSCH + LOMB CORP (BLCO.CA) Stock Fundamental Analysis

Canada • Toronto Stock Exchange • TSX:BLCO • CA0717051076

22.15 CAD
+0.05 (+0.23%)
Last: Feb 3, 2026, 07:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to BLCO. BLCO was compared to 16 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of BLCO while its profitability can be described as average. BLCO is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • BLCO had positive earnings in the past year.
  • BLCO had a positive operating cash flow in the past year.
  • In multiple years BLCO reported negative net income over the last 5 years.
  • BLCO had a positive operating cash flow in 4 of the past 5 years.
BLCO.CA Yearly Net Income VS EBIT VS OCF VS FCFBLCO.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M

1.2 Ratios

  • BLCO's Return On Assets of -2.21% is amongst the best of the industry. BLCO outperforms 100.00% of its industry peers.
  • BLCO's Return On Equity of -4.74% is amongst the best of the industry. BLCO outperforms 100.00% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 0.70%, BLCO belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for BLCO is in line with the industry average of 0.70%.
Industry RankSector Rank
ROA -2.21%
ROE -4.74%
ROIC 0.7%
ROA(3y)-1.41%
ROA(5y)-0.54%
ROE(3y)-2.87%
ROE(5y)-1.37%
ROIC(3y)1.45%
ROIC(5y)1.75%
BLCO.CA Yearly ROA, ROE, ROICBLCO.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 2 -2 -4

1.3 Margins

  • Looking at the Operating Margin, with a value of 2.33%, BLCO belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • In the last couple of years the Operating Margin of BLCO has declined.
  • With a decent Gross Margin value of 59.45%, BLCO is doing good in the industry, outperforming 68.75% of the companies in the same industry.
  • In the last couple of years the Gross Margin of BLCO has remained more or less at the same level.
Industry RankSector Rank
OM 2.33%
PM (TTM) N/A
GM 59.45%
OM growth 3Y-22.07%
OM growth 5Y-17.92%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.06%
GM growth 5Y-1.25%
BLCO.CA Yearly Profit, Operating, Gross MarginsBLCO.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

3

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BLCO is destroying value.
  • The number of shares outstanding for BLCO has been increased compared to 1 year ago.
  • Compared to 5 years ago, BLCO has more shares outstanding
  • The debt/assets ratio for BLCO is higher compared to a year ago.
BLCO.CA Yearly Shares OutstandingBLCO.CA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 100M 200M 300M
BLCO.CA Yearly Total Debt VS Total AssetsBLCO.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

  • BLCO has an Altman-Z score of 0.87. This is a bad value and indicates that BLCO is not financially healthy and even has some risk of bankruptcy.
  • BLCO has a better Altman-Z score (0.87) than 87.50% of its industry peers.
  • BLCO has a Debt/Equity ratio of 0.77. This is a neutral value indicating BLCO is somewhat dependend on debt financing.
  • BLCO's Debt to Equity ratio of 0.77 is fine compared to the rest of the industry. BLCO outperforms 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF N/A
Altman-Z 0.87
ROIC/WACC0.07
WACC9.78%
BLCO.CA Yearly LT Debt VS Equity VS FCFBLCO.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

  • A Current Ratio of 1.51 indicates that BLCO should not have too much problems paying its short term obligations.
  • BLCO has a better Current ratio (1.51) than 87.50% of its industry peers.
  • A Quick Ratio of 0.98 indicates that BLCO may have some problems paying its short term obligations.
  • BLCO has a better Quick ratio (0.98) than 81.25% of its industry peers.
Industry RankSector Rank
Current Ratio 1.51
Quick Ratio 0.98
BLCO.CA Yearly Current Assets VS Current LiabilitesBLCO.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

More info and screens

3

3. Growth

3.1 Past

  • The earnings per share for BLCO have decreased strongly by -29.51% in the last year.
  • BLCO shows a small growth in Revenue. In the last year, the Revenue has grown by 6.23%.
  • The Revenue has been growing slightly by 4.87% on average over the past years.
EPS 1Y (TTM)-29.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.88%
Revenue 1Y (TTM)6.23%
Revenue growth 3Y8.36%
Revenue growth 5Y4.87%
Sales Q2Q%7.11%

3.2 Future

  • Based on estimates for the next years, BLCO will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.96% on average per year.
  • BLCO is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.49% yearly.
EPS Next Y-10.98%
EPS Next 2Y13.94%
EPS Next 3Y20.44%
EPS Next 5Y19.96%
Revenue Next Year6.46%
Revenue Next 2Y6.14%
Revenue Next 3Y5.92%
Revenue Next 5Y5.49%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
BLCO.CA Yearly Revenue VS EstimatesBLCO.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B
BLCO.CA Yearly EPS VS EstimatesBLCO.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0.5 1 1.5 2

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 37.54, the valuation of BLCO can be described as expensive.
  • Based on the Price/Earnings ratio, BLCO is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of BLCO to the average of the S&P500 Index (28.18), we can say BLCO is valued slightly more expensively.
  • The Price/Forward Earnings ratio is 20.17, which indicates a rather expensive current valuation of BLCO.
  • Based on the Price/Forward Earnings ratio, BLCO is valued cheaper than 100.00% of the companies in the same industry.
  • BLCO's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.51.
Industry RankSector Rank
PE 37.54
Fwd PE 20.17
BLCO.CA Price Earnings VS Forward Price EarningsBLCO.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BLCO indicates a rather cheap valuation: BLCO is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 19.51
BLCO.CA Per share dataBLCO.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

  • BLCO has a very decent profitability rating, which may justify a higher PE ratio.
  • BLCO's earnings are expected to grow with 20.44% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y13.94%
EPS Next 3Y20.44%

More info and screens

0

5. Dividend

5.1 Amount

  • No dividends for BLCO!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

BAUSCH + LOMB CORP

TSX:BLCO (2/3/2026, 7:00:00 PM)

22.15

+0.05 (+0.23%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-29
Earnings (Next)02-18
Inst Owners11.05%
Inst Owner ChangeN/A
Ins Owners0.45%
Ins Owner ChangeN/A
Market Cap7.85B
Revenue(TTM)4.98B
Net Income(TTM)-305.00M
Analysts72.63
Price Target24.45 (10.38%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.13%
Min EPS beat(2)1.79%
Max EPS beat(2)8.47%
EPS beat(4)3
Avg EPS beat(4)-86.5%
Min EPS beat(4)-360.35%
Max EPS beat(4)8.47%
EPS beat(8)6
Avg EPS beat(8)-37.66%
EPS beat(12)9
Avg EPS beat(12)-24.06%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.15%
Min Revenue beat(2)-1.91%
Max Revenue beat(2)-0.39%
Revenue beat(4)0
Avg Revenue beat(4)-1.38%
Min Revenue beat(4)-3.07%
Max Revenue beat(4)-0.16%
Revenue beat(8)3
Avg Revenue beat(8)0.21%
Revenue beat(12)6
Avg Revenue beat(12)0.82%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)7.87%
PT rev (3m)13.92%
EPS NQ rev (1m)-3.3%
EPS NQ rev (3m)-8.05%
EPS NY rev (1m)0%
EPS NY rev (3m)2.3%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.78%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.21%
Valuation
Industry RankSector Rank
PE 37.54
Fwd PE 20.17
P/S 1.16
P/FCF N/A
P/OCF 34.02
P/B 0.89
P/tB N/A
EV/EBITDA 19.51
EPS(TTM)0.59
EY2.66%
EPS(NY)1.1
Fwd EY4.96%
FCF(TTM)-0.76
FCFYN/A
OCF(TTM)0.65
OCFY2.94%
SpS19.17
BVpS24.77
TBVpS-5.99
PEG (NY)N/A
PEG (5Y)N/A
Graham Number18.13
Profitability
Industry RankSector Rank
ROA -2.21%
ROE -4.74%
ROCE 0.97%
ROIC 0.7%
ROICexc 0.72%
ROICexgc 2.29%
OM 2.33%
PM (TTM) N/A
GM 59.45%
FCFM N/A
ROA(3y)-1.41%
ROA(5y)-0.54%
ROE(3y)-2.87%
ROE(5y)-1.37%
ROIC(3y)1.45%
ROIC(5y)1.75%
ROICexc(3y)1.5%
ROICexc(5y)1.8%
ROICexgc(3y)4.98%
ROICexgc(5y)6.16%
ROCE(3y)2.02%
ROCE(5y)2.43%
ROICexgc growth 3Y-21.86%
ROICexgc growth 5Y-17.06%
ROICexc growth 3Y-20.45%
ROICexc growth 5Y-15.79%
OM growth 3Y-22.07%
OM growth 5Y-17.92%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.06%
GM growth 5Y-1.25%
F-Score4
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF N/A
Debt/EBITDA 9.05
Cap/Depr 85.28%
Cap/Sales 7.34%
Interest Coverage 250
Cash Conversion 31.07%
Profit Quality N/A
Current Ratio 1.51
Quick Ratio 0.98
Altman-Z 0.87
F-Score4
WACC9.78%
ROIC/WACC0.07
Cap/Depr(3y)53.43%
Cap/Depr(5y)52.81%
Cap/Sales(3y)5.03%
Cap/Sales(5y)5.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-29.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.88%
EPS Next Y-10.98%
EPS Next 2Y13.94%
EPS Next 3Y20.44%
EPS Next 5Y19.96%
Revenue 1Y (TTM)6.23%
Revenue growth 3Y8.36%
Revenue growth 5Y4.87%
Sales Q2Q%7.11%
Revenue Next Year6.46%
Revenue Next 2Y6.14%
Revenue Next 3Y5.92%
Revenue Next 5Y5.49%
EBIT growth 1Y-38.95%
EBIT growth 3Y-15.55%
EBIT growth 5Y-13.93%
EBIT Next Year46.23%
EBIT Next 3Y23.51%
EBIT Next 5Y15.82%
FCF growth 1Y-880%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y33.07%
OCF growth 3Y-35.71%
OCF growth 5Y-21.91%

BAUSCH + LOMB CORP / BLCO.CA FAQ

What is the fundamental rating for BLCO stock?

ChartMill assigns a fundamental rating of 4 / 10 to BLCO.CA.


What is the valuation status of BAUSCH + LOMB CORP (BLCO.CA) stock?

ChartMill assigns a valuation rating of 4 / 10 to BAUSCH + LOMB CORP (BLCO.CA). This can be considered as Fairly Valued.


Can you provide the profitability details for BAUSCH + LOMB CORP?

BAUSCH + LOMB CORP (BLCO.CA) has a profitability rating of 6 / 10.


What is the financial health of BAUSCH + LOMB CORP (BLCO.CA) stock?

The financial health rating of BAUSCH + LOMB CORP (BLCO.CA) is 3 / 10.